Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Training leg reflexes to reduce neuropathic pain after spinal cord injury

Official title: Targeted Spinal Cord Plasticity for Alleviating SCI-related Neuropathic Pain

Run by Medical University of South Carolina · NCT05492188 · Data updated 2026-11-12

This study is testing whether training leg reflexes can help reduce neuropathic pain in people with spinal cord injuries.

More Neuropathic Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorMedical University of South Carolina
Academic / other
Locations1 site (Charleston, South Carolina)
StatusRecruiting
StartedMarch 27, 2023
Main results expectedJanuary 15, 2027
Study endsJanuary 15, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT05492188 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who are neurologically stable, at least one year post spinal cord injury, and experiencing neuropathic pain in the lower leg.

Probably not a fit

Patients with motoneuron injury, uncontrolled peripheral neuropathy, or significant cognitive impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate the effects of reflex training on reducing neuropathic pain in individuals with spinal cord injuries. It involves recruiting 15 participants with neuropathic pain to undergo operant conditioning of cutaneous reflexes over approximately 50 visits spanning 6.5 months. The study also includes assessments of reflexes and sensation in the leg, along with questionnaires on pain and quality of life for both participants with and without neuropathic pain. The goal is to understand the relationship between reflexes and neuropathic pain and to explore potential therapeutic interventions.

Why it matters

Potential benefit: If successful, this approach could significantly alleviate neuropathic pain for patients with spinal cord injuries.

How similar studies have gone: While the specific approach of operant conditioning for neuropathic pain is novel, similar studies exploring reflex training have shown promise in related areas.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. neurologically stable (\>1 year post SCI)
2. medical clearance to participate
3. ability to stand with or without an assistive device for at least 3 minutes at a time
4. expectation that current medication will be maintained without change for at least 3 months (stable use of anti-spasticity medication is accepted)
5. For participants with neuropathic pain, the area of neuropathic pain must include lower leg.

Exclusion Criteria:

1. motoneuron injury
2. known cardiac condition
3. medically unstable condition (incl. pregnancy)
4. cognitive impairment
5. uncontrolled peripheral neuropathy
6. frequent use of electrical spinal stimulation (either transcutaneous or epidural) for pain treatment
7. daily use of electrical stimulation to the leg
8. complete lack of cutaneous sensation around foot.

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Aiko Thompson, PhD — Medical University of South Carolina
  • Study coordinator: Blair Dellenbach, MSOT
  • Email: stecb@musc.edu
  • Phone: 843-792-6313

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.